Artificial Intelligence

AI in Precision Oncology and How It Can Redefine Cancer Care

Published

Peter Casasanto, Chief Biopharma Officer of Sophia Genetics, joins Jill Malandrino on Nasdaq TradeTalks to discuss AI in precision oncology and how it can redefine cancer care.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now